150 related articles for article (PubMed ID: 15996628)
21. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
Trevisani L; Sartori S; Caselli M; Ruina M; Verdianelli G; Abbasciano V
Am J Gastroenterol; 1998 Mar; 93(3):390-3. PubMed ID: 9517646
[TBL] [Abstract][Full Text] [Related]
22. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
[TBL] [Abstract][Full Text] [Related]
23. Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori.
Hu TH; Chuah SK; Hsu PI; Wu DC; Tai WC; Chiu YC; Wu KL; Kuo CM; Hu ML
Am J Med Sci; 2011 Sep; 342(3):177-81. PubMed ID: 21804375
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Manes G; Efrati C; Hassan C; Maconi G; Piglionica D; Cannaviello C; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2007 Sep; 39(9):806-10. PubMed ID: 17644057
[TBL] [Abstract][Full Text] [Related]
25. High-dose versus low-dose esomeprazole-based triple therapy for Helicobacter pylori infection.
Hsu PI; Lai KH; Wu CJ; Tseng HH; Tsay FW; Peng NJ; Chen TA; Chuah SK; Lin WS; Lo GH
Eur J Clin Invest; 2007 Sep; 37(9):724-30. PubMed ID: 17696962
[TBL] [Abstract][Full Text] [Related]
26. Azithromycin effect on helicobacter pylori eradication: double blind randomized clinical trial.
Rogha M; Pourmoghaddas Z; Rezaee M; Shirneshan K; Shahi Z
Hepatogastroenterology; 2009; 56(91-92):722-4. PubMed ID: 19621690
[TBL] [Abstract][Full Text] [Related]
27. Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication.
Schrauwen RW; Janssen MJ; de Boer WA
Neth J Med; 2009 Mar; 67(3):96-101. PubMed ID: 19307680
[TBL] [Abstract][Full Text] [Related]
28. A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures.
Lee YC; Wu HM; Chen TH; Liu TY; Chiu HM; Chang CC; Wang HP; Wu MS; Chiang H; Wu MC; Lin JT
Helicobacter; 2006 Oct; 11(5):418-24. PubMed ID: 16961802
[TBL] [Abstract][Full Text] [Related]
29. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
30. Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
Kang JM; Kim N; Lee DH; Park YS; Kim YR; Kim JS; Jung HC; Song IS
Helicobacter; 2007 Dec; 12(6):623-8. PubMed ID: 18001404
[TBL] [Abstract][Full Text] [Related]
31. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.
Tulassay Z; Stolte M; Sjölund M; Engstrand L; Butruk E; Malfertheiner P; Dite P; Tchernev K; Wong BC; Gottlow M; Eklund S; Wrangstadh M; Nagy P
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):526-36. PubMed ID: 18467912
[TBL] [Abstract][Full Text] [Related]
32. High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates.
Sánchez-Delgado J; García-Iglesias P; Castro-Fernández M; Bory F; Barenys M; Bujanda L; Lisozain J; Calvo MM; Torra S; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2012 Jul; 36(2):190-6. PubMed ID: 22591220
[TBL] [Abstract][Full Text] [Related]
33. Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children.
Arenz T; Antos D; Rüssmann H; Alberer M; Buderus S; Kappler M; Koletzko S
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):180-4. PubMed ID: 16877981
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
[TBL] [Abstract][Full Text] [Related]
35. Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial.
Cuadrado-Lavín A; Salcines-Caviedes JR; Carrascosa MF; Dierssen-Sotos T; Cobo M; Campos MR; Ayestarán B; Fernández-Pousa A; González-Colominas E; Aresti-Zárate S; Hernández M; Pascual EL
J Antimicrob Chemother; 2012 Sep; 67(9):2254-9. PubMed ID: 22687889
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Pontone S; Standoli M; Angelini R; Pontone P
Dig Liver Dis; 2010 Aug; 42(8):541-3. PubMed ID: 20061196
[TBL] [Abstract][Full Text] [Related]
37. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
Cheng HC; Chang WL; Chen WY; Yang HB; Wu JJ; Sheu BS
Helicobacter; 2007 Aug; 12(4):359-63. PubMed ID: 17669110
[TBL] [Abstract][Full Text] [Related]
38. Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice.
Zullo A; De Francesco V; Manes G; Scaccianoce G; Cristofari F; Hassan C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):131-4. PubMed ID: 20593044
[TBL] [Abstract][Full Text] [Related]
39. Azithromycin in one week quadruple therapy for H pylori eradication in Iran.
Mousavi S; Toussy J; Yaghmaie S; Zahmatkesh M
World J Gastroenterol; 2006 Jul; 12(28):4553-6. PubMed ID: 16874871
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial.
Kuo CH; Hsu PI; Kuo FC; Wang SS; Hu HM; Liu CJ; Chuah SK; Chen YH; Hsieh MC; Wu DC; Tseng HH
J Antimicrob Chemother; 2013 Jan; 68(1):222-8. PubMed ID: 22984204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]